Roivant Sciences Ltd. (ROIV)
USD 9.0
(-4.86%)
USD 9.0
(-4.86%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -996.51 Million USD | 10.03% |
| 2023 | 4.31 Billion USD | 26.15% |
| 2022 | -1.17 Billion USD | -193.79% |
| 2021 | -916.7 Million USD | -708.79% |
| 2020 | -895.73 Million USD | -39.29% |
| 2019 | -553.3 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - USD | 10.03% |
| 2024 Q1 | -291.27 Million USD | -103.5% |
| 2024 Q2 | -270.08 Million USD | -24.29% |
| 2024 Q3 | -224.77 Million USD | 16.77% |
| 2024 Q4 | -210.37 Million USD | 6.41% |
| 2023 Q1 | -322.62 Million USD | -64.69% |
| 2023 FY | - USD | 26.15% |
| 2023 Q4 | -203.1 Million USD | 8.12% |
| 2023 Q3 | -221.04 Million USD | 17.37% |
| 2023 Q2 | -267.5 Million USD | 17.09% |
| 2022 Q4 | -195.9 Million USD | 5.81% |
| 2022 FY | - USD | -193.79% |
| 2022 Q3 | -207.98 Million USD | 82.08% |
| 2022 Q2 | -1.16 Billion USD | -446.77% |
| 2022 Q1 | -212.24 Million USD | -187.65% |
| 2021 Q1 | -242.11 Million USD | -1056.11% |
| 2021 Q2 | -269.68 Million USD | -11.39% |
| 2021 Q4 | 242.13 Million USD | 200.54% |
| 2021 Q3 | -240.83 Million USD | 10.7% |
| 2021 FY | - USD | -708.79% |
| 2020 Q4 | 25.32 Million USD | 0.0% |
| 2020 FY | - USD | -39.29% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -418.591% |
| Alkermes plc | 495.04 Million USD | 301.296% |
| Agenus Inc. | -145.92 Million USD | -582.9% |
| Aptorum Group Limited | -9.59 Million USD | -10281.449% |
| Ardelyx, Inc. | -55.35 Million USD | -1700.258% |
| Dyadic International, Inc. | -8.22 Million USD | -12008.707% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -342345.017% |
| Lantern Pharma Inc. | -15.78 Million USD | -6212.375% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -4904.496% |
| Novavax, Inc. | -487.39 Million USD | -104.459% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -1303.068% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -1169.559% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -5444.372% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -9897.141% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -1636.817% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -162.262% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -4032.876% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 188477.127% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -533.936% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -1231.975% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -4843.276% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -4098.504% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -4221.776% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -716.127% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -285.884% |
| AlloVir, Inc. | -190.14 Million USD | -424.079% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -467.259% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -3305.957% |
| Bicycle Therapeutics plc | -183.4 Million USD | -443.356% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -502.411% |
| ChromaDex Corporation | -3.89 Million USD | -25491.037% |
| Chimerix, Inc. | -92.97 Million USD | -971.821% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -2142.55% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -785.523% |
| CRISPR Therapeutics AG | -202.7 Million USD | -391.618% |
| Precision BioSciences, Inc. | -32.04 Million USD | -3010.027% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -478.599% |
| Fortress Biotech, Inc. | -133.64 Million USD | -645.654% |
| Fortress Biotech, Inc. | -133.64 Million USD | -645.654% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -1188.436% |
| ImmuCell Corporation | -2.5 Million USD | -39695.701% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -664.076% |
| Immix Biopharma, Inc. | -16.13 Million USD | -6075.861% |
| Incyte Corporation | 919.42 Million USD | 208.384% |
| Innoviva, Inc. | 248.96 Million USD | 500.271% |
| IO Biotech, Inc. | -91.22 Million USD | -992.335% |
| Jaguar Health, Inc. | -33.13 Million USD | -2907.802% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -554.839% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 1079.597% |
| ContextLogic Inc. | -324 Million USD | -207.566% |
| MiMedx Group, Inc. | 40.51 Million USD | 2559.498% |
| MEI Pharma, Inc. | 26.38 Million USD | 3877.54% |
| NextCure, Inc. | -59.03 Million USD | -1587.893% |
| Onconetix, Inc. | -36.7 Million USD | -2614.802% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 44686.801% |
| Opthea Limited | -200.01 Million USD | -398.211% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -36116.101% |
| Vaxcyte, Inc. | -464.88 Million USD | -114.357% |
| PDS Biotechnology Corporation | -40.08 Million USD | -2386.007% |
| Precigen, Inc. | -89.22 Million USD | -1016.844% |
| Pharming Group N.V. | 9.87 Million USD | 10189.248% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -526.546% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -4277.976% |
| PureTech Health plc | -11.62 Million USD | -8470.698% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -5768.412% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -326.779% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -4032.876% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -1039.825% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -3340.648% |
| Acelyrin, Inc. | -381.52 Million USD | -161.192% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -7733881.431% |
| Summit Therapeutics Inc. | 1 Million USD | 99651.948% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -2884.829% |
| Senti Biosciences, Inc. | -61.33 Million USD | -1524.682% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -787.337% |
| Elevation Oncology, Inc. | -41.46 Million USD | -2303.152% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -3124.55% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -16192.12% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -310340.81% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -2970.641% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -11768.926% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -1595.042% |
| Seer, Inc. | -97.88 Million USD | -918.047% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -1502.191% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -1424.539% |
| ESSA Pharma Inc. | -26.45 Million USD | -3666.786% |
| GlycoMimetics, Inc. | -39.12 Million USD | -2447.199% |
| GT Biopharma, Inc. | 5.97 Million USD | 16766.918% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -382.123% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -14409.537% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 1247.9% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -1655.85% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -1845.596% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -9979.14% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | -84.564% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -14375.813% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -2026.488% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -321.142% |
| Aptose Biosciences Inc. | -52.26 Million USD | -1806.549% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -824.897% |
| Soligenix, Inc. | -7.85 Million USD | -12589.851% |
| Century Therapeutics, Inc. | -121.2 Million USD | -722.153% |
| Kura Oncology, Inc. | -164.95 Million USD | -504.113% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -1144.12% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -9780.18% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -103948.702% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -23026.363% |
| Autolus Therapeutics plc | -156.77 Million USD | -535.654% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -1077.121% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -1344.204% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -4899.072% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -426.496% |
| GRI Bio, Inc. | -10.89 Million USD | -9044.017% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -21967.712% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -713.442% |
| IGM Biosciences, Inc. | -253.35 Million USD | -293.323% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -860.108% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -2513.246% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -6400.039% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -6229.795% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -1653.039% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -830.427% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -274.634% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -413.829% |
| Verastem, Inc. | -83.16 Million USD | -1098.224% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -1870.488% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -529.797% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -773.454% |
| Histogen Inc. | -10.5 Million USD | -9387.908% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -6878.539% |
| Surrozen, Inc. | -41.13 Million USD | -2322.783% |
| Organovo Holdings, Inc. | -14.8 Million USD | -6630.481% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 31073221.297% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -1597.259% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -1842.752% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -4526.561% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -11851.48% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -500.071% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -1923.033% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -4023.624% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -6519.146% |
| Apollomics, Inc. | -171.74 Million USD | -480.223% |
| Amarin Corporation plc | -50.9 Million USD | -1857.731% |
| Mesoblast Limited | -61.33 Million USD | -1524.815% |
| Turnstone Biologics Corp. | -56.23 Million USD | -1672.086% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -595.886% |
| Synaptogenix, Inc. | -8.3 Million USD | -11895.356% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -6396.61% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -1480.591% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -20697.706% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 232366.764% |
| Exelixis, Inc. | 196.6 Million USD | 606.869% |
| Better Therapeutics, Inc. | -38.26 Million USD | -2504.451% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -604.704% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | -101.23% |
| NLS Pharmaceutics AG | -11.79 Million USD | -8348.153% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 403194.864% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -3277.33% |
| Gritstone bio, Inc. | -126.86 Million USD | -685.505% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -1433.454% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -24813.211% |
| Avid Bioservices, Inc. | -11.48 Million USD | -8579.688% |
| Insmed Incorporated | -654.73 Million USD | -52.2% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -44195.088% |
| MediWound Ltd. | -4.89 Million USD | -20266.135% |
| OmniAb, Inc. | -49.73 Million USD | -1903.811% |
| Alector, Inc. | -142.89 Million USD | -597.39% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -1066.415% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -1810.936% |
| Zai Lab Limited | -366.57 Million USD | -171.846% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -242.873% |
| Aura Biosciences, Inc. | -83.69 Million USD | -1090.636% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -342.406% |
| Immunic, Inc. | -99.11 Million USD | -905.443% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -656.828% |
| Veracyte, Inc. | -49.4 Million USD | -1916.869% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -14007.089% |
| FibroGen, Inc. | -261.4 Million USD | -281.215% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -8844.574% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -14133.228% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -5224.155% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 168.753% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -3819.892% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 2598.157% |
| TG Therapeutics, Inc. | 26.1 Million USD | 3918.065% |
| Galecto, Inc. | -37.51 Million USD | -2556.028% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -2504.247% |
| Fortrea Holdings Inc. | 167.3 Million USD | 695.646% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -642.117% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -3419.886% |
| XBiotech Inc. | -35.76 Million USD | -2686.208% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -1433.454% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -1427.226% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -854.014% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -3781.719% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -2338.434% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | -92.953% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -1678.824% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -1777771.938% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -756.591% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -4394.971% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -323.933% |
| NexImmune, Inc. | -28.16 Million USD | -3437.817% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -17934.682% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -8350.577% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 121.411% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -3824.523% |
| Scopus BioPharma Inc. | -11.71 Million USD | -8407.661% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -691.853% |
| Ainos, Inc. | -8.77 Million USD | -11258.758% |
| Pluri Inc. | -20.22 Million USD | -4827.145% |
| Prothena Corporation plc | -190.1 Million USD | -424.184% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -677.325% |
| Celularity Inc. | -183.94 Million USD | -441.743% |
| Rallybio Corporation | -72.37 Million USD | -1276.915% |
| Cue Biopharma, Inc. | -46.05 Million USD | -2063.891% |
| MeiraGTx Holdings plc | -57.05 Million USD | -1646.678% |
| Omeros Corporation | -163.61 Million USD | -509.08% |
| Humacyte, Inc. | -96.45 Million USD | -933.108% |
| Immunocore Holdings plc | -59.64 Million USD | -1570.632% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -5044.1% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -3989.945% |
| Blueprint Medicines Corporation | -474.61 Million USD | -109.964% |
| CalciMedica, Inc. | -34.18 Million USD | -2814.724% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -1260.727% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -694.055% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -491.576% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -294.831% |
| Pulmatrix, Inc. | -12.64 Million USD | -7780.081% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -2922.857% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -1026.426% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | -96.817% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -884.553% |
| Cytokinetics, Incorporated | -456.68 Million USD | -118.207% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -2885.992% |
| Nutriband Inc. | -5.12 Million USD | -19356.431% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -2202.91% |
| Vor Biopharma Inc. | -114.37 Million USD | -771.3% |
| Evogene Ltd. | -23.2 Million USD | -4194.583% |
| ProKidney Corp. | -147.66 Million USD | -574.83% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -1444.147% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -650583.321% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | -76.228% |
| CorMedix Inc. | -48.88 Million USD | -1938.404% |
| BioLineRx Ltd. | -57.06 Million USD | -1646.403% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -791.672% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -493224.257% |
| Atai Life Sciences N.V. | -36.31 Million USD | -2644.389% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -1153.21% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -1125.53% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -261.707% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -3141.753% |
| MediciNova, Inc. | -9.87 Million USD | -9986.215% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -691.255% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -65023.144% |
| GeoVax Labs, Inc. | -26.66 Million USD | -3636.637% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -342.913% |
| Biomea Fusion, Inc. | -124.62 Million USD | -699.643% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -201.663% |
| Mereo BioPharma Group plc | -26.05 Million USD | -3724.513% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -423.547% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -333.377% |
| Absci Corporation | -95.45 Million USD | -943.941% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -3218.951% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -830.296% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -326.817% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -4260.162% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -379.472% |
| Allakos Inc. | -189.91 Million USD | -424.716% |
| Imunon, Inc. | -19.87 Million USD | -4913.085% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -818.515% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 1019.939% |
| BioAtla, Inc. | -122.24 Million USD | -715.205% |
| NLS Pharmaceutics AG | -11.79 Million USD | -8348.153% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -6222.664% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -231.848% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -2304.312% |
| XOMA Corporation | -39.36 Million USD | -2431.668% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -904.005% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -747.017% |
| aTyr Pharma, Inc. | -52.17 Million USD | -1809.837% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -1088.946% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -570.462% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -324.835% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -7198.872% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -12290.921% |
| Akari Therapeutics, Plc | -16.8 Million USD | -5830.931% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 528178.069% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 320.494% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -15498.27% |
| UroGen Pharma Ltd. | -63.83 Million USD | -1461.177% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -1367.297% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -13620.41% |
| Orgenesis Inc. | -60.71 Million USD | -1541.218% |
| Entera Bio Ltd. | -8.8 Million USD | -11218.889% |
| GH Research PLC | -41.15 Million USD | -2321.488% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -3804.992% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -1111.819% |
| Xencor, Inc. | -125.87 Million USD | -691.677% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -69755.14% |
| Replimune Group, Inc. | -230.19 Million USD | -332.895% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -4843.615% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -9007.247% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -15498.27% |
| Portage Biotech Inc. | -18.19 Million USD | -5375.658% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -65023.144% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -852.837% |
| OncoCyte Corporation | -23.12 Million USD | -4209.627% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -8718.434% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -8597.993% |
| Purple Biotech Ltd. | -22.22 Million USD | -4383.757% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -15446.256% |
| scPharmaceuticals Inc. | -46.06 Million USD | -2063.468% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -5495.355% |
| HilleVax, Inc. | -132.46 Million USD | -652.28% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -9271.908% |
| Tharimmune, Inc. | -9.3 Million USD | -10612.233% |
| Genprex, Inc. | -31.06 Million USD | -3108.296% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -431.401% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -3078.271% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -130333.901% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 660463.542% |
| OKYO Pharma Limited | -15.74 Thousand USD | -6328638.901% |
| Savara Inc. | -59.13 Million USD | -1585.21% |
| Curis, Inc. | -45.13 Million USD | -2107.659% |
| Daré Bioscience, Inc. | -30.7 Million USD | -3145.817% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -6459.84% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -13808.095% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -3627.519% |
| BeiGene, Ltd. | -1.12 Billion USD | 11.39% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -6013.139% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -131.434% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -1003.072% |
| Erasca, Inc. | -121.31 Million USD | -721.462% |
| bluebird bio, Inc. | -167.16 Million USD | -496.141% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -22050.901% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 421.162% |
| DBV Technologies S.A. | -85.98 Million USD | -1058.981% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -22050.901% |
| Moderna, Inc. | -3.28 Billion USD | 69.646% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -2238.743% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -17543.679% |
| Molecular Templates, Inc. | 1.43 Million USD | 69786.364% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -1564.965% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -205.449% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -626.911% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -2003.861% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -616.742% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -384.074% |
| MacroGenics, Inc. | 2.01 Million USD | 49505.801% |
| RenovoRx, Inc. | -11.39 Million USD | -8649.034% |
| Adicet Bio, Inc. | -136.53 Million USD | -629.86% |
| Prime Medicine, Inc. | -193.75 Million USD | -414.306% |
| Aditxt, Inc. | -25.45 Million USD | -3814.355% |
| Adagene Inc. | -14.95 Million USD | -6565.302% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -13532.033% |
| Quantum-Si incorporated | -91.8 Million USD | -985.481% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 239.88% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 888.039% |
| SciSparc Ltd. | -5.28 Million USD | -18766.244% |
| Vericel Corporation | 2.86 Million USD | 34894.518% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -1046571.498% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -4494.05% |
| Generation Bio Co. | -133.3 Million USD | -647.573% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -1100.187% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -1058.429% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -338.156% |
| Invivyd, Inc. | -196.61 Million USD | -406.836% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -166.339% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -10644.331% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 3769.864% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -9589.013% |
| 2seventy bio, Inc. | -206.41 Million USD | -382.766% |
| ADMA Biologics, Inc. | 5.12 Million USD | 19563.184% |
| Clene Inc. | -43.24 Million USD | -2204.56% |
| Capricor Therapeutics, Inc. | -23 Million USD | -4230.984% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -1955.645% |
| GeoVax Labs, Inc. | -26.66 Million USD | -3636.637% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -232.653% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -2613.13% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 4327.358% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 20394.567% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -2967.899% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -529.097% |
| Vir Biotechnology, Inc. | -684.3 Million USD | -45.624% |
| Evaxion Biotech A/S | -21.4 Million USD | -4555.959% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -1400.437% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -357.812% |
| Trevena, Inc. | -35.28 Million USD | -2723.949% |
| Surrozen, Inc. | -41.13 Million USD | -2322.783% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -1152.029% |
| Cingulate Inc. | -22.95 Million USD | -4241.729% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -13256.32% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -2572.84% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -12013.665% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -874.434% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -1369.201% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -1607.18% |
| Clearmind Medicine Inc. | -8.71 Million USD | -11340.175% |
| Kronos Bio, Inc. | -121.83 Million USD | -717.955% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -1240.447% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -40717.125% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -888.341% |
| Statera Biopharma, Inc. | 38.93 Million USD | 2659.435% |
| ImmunityBio, Inc. | -436.18 Million USD | -128.463% |
| Korro Bio, Inc. | -80.9 Million USD | -1131.725% |
| Kineta, Inc. | -15.71 Million USD | -6241.574% |
| BioVie Inc. | -31.95 Million USD | -3018.962% |
| Codexis, Inc. | -49.28 Million USD | -1922.026% |
| Celularity Inc. | -183.94 Million USD | -441.743% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -349.874% |
| Celcuity Inc. | -58.3 Million USD | -1608.996% |
| Virax Biolabs Group Limited | -6.6 Million USD | -14977.822% |
| Cibus, Inc. | -314.58 Million USD | -216.771% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -2854.125% |
| IN8bio, Inc. | -28.5 Million USD | -3396.053% |
| Kodiak Sciences Inc. | -259.02 Million USD | -284.721% |
| Annexon, Inc. | -141.57 Million USD | -603.878% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -785.012% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -1452.301% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -3464.711% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -333.249% |
| Eyenovia, Inc. | -24.1 Million USD | -4033.882% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 2325.159% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -307466.358% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -1250.218% |
| Arcellx, Inc. | -64.14 Million USD | -1453.535% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -2113.789% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -707.052% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -3126.847% |
| Moolec Science SA | -52.07 Million USD | -1813.595% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -1831.006% |
| Geron Corporation | -174.78 Million USD | -470.147% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -2365.584% |
| Royalty Pharma plc | 1.88 Billion USD | 152.802% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -733.255% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -10587.343% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -4704.623% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -500.021% |
| Humacyte, Inc. | -96.45 Million USD | -933.108% |
| Structure Therapeutics Inc. | -102.45 Million USD | -872.599% |
| 89bio, Inc. | -134.46 Million USD | -641.107% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -1163.41% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 24693.164% |
| Genelux Corporation | -24.16 Million USD | -4023.795% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -2848.269% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -509.624% |
| Notable Labs, Ltd. | -14.4 Million USD | -6820.243% |
| Liquidia Corporation | -70.05 Million USD | -1322.556% |
| Mustang Bio, Inc. | -48.06 Million USD | -1973.352% |
| Immunovant, Inc. | -269.97 Million USD | -269.11% |
| Quantum-Si incorporated | -91.8 Million USD | -985.481% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -1303.819% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -5061.151% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -876.861% |
| Acasti Pharma Inc. | -11.3 Million USD | -8717.936% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -4378.067% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -6400.039% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -373.375% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -23235.713% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -6175.283% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -3363.007% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -2591.102% |
| PepGen Inc. | -83.58 Million USD | -1092.26% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -3277.559% |
| United Therapeutics Corporation | 1.38 Billion USD | 171.857% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -4252.164% |
| Solid Biosciences Inc. | -93.43 Million USD | -966.544% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -20783.699% |
| Immuneering Corporation | -58.06 Million USD | -1616.33% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 31073221.297% |
| Silo Pharma, Inc. | -3.62 Million USD | -27380.866% |
| Belite Bio, Inc | -31.52 Million USD | -3060.63% |
| XOMA Corporation | -39.36 Million USD | -2431.668% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -1377.479% |
| Bionomics Limited | -9.83 Million USD | -10030.279% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -1086.539% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -2779.602% |
| uniQure N.V. | -253.1 Million USD | -293.724% |
| Cassava Sciences, Inc. | -95.68 Million USD | -941.432% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -13532.033% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -669.486% |
| Forte Biosciences, Inc. | -32.47 Million USD | -2968.372% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -12278.341% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -3431.362% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -307466.358% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -8844.574% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -6166.996% |
| Altimmune, Inc. | -87.93 Million USD | -1033.24% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -982.239% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -2779.602% |
| Compugen Ltd. | -12.51 Million USD | -7861.929% |
| Peak Bio, Inc. | -1356.23 USD | -73476743.898% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -1950.527% |
| Benitec Biopharma Inc. | -22.49 Million USD | -4330.925% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -311.268% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -3391.276% |
| Zura Bio Limited | -60.56 Million USD | -1545.419% |
| PolyPid Ltd. | -20.26 Million USD | -4817.905% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -6282.598% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -3391.276% |
| Instil Bio, Inc. | -146.12 Million USD | -581.975% |
| argenx SE | -216.02 Million USD | -361.3% |
| Immunome, Inc. | -28.27 Million USD | -3424.866% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -1955.815% |
| Verona Pharma plc | -52.46 Million USD | -1799.296% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -951.487% |
| Shattuck Labs, Inc. | -87.61 Million USD | -1037.379% |
| CervoMed Inc. | -2.17 Million USD | -45782.726% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -715.185% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -7750.902% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -1968.574% |
| Moolec Science SA | -52.07 Million USD | -1813.595% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -5713.979% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -664.251% |
| AnaptysBio, Inc. | -143.16 Million USD | -596.065% |
| Design Therapeutics, Inc. | -66.32 Million USD | -1402.473% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -1130.463% |
| NeurAxis, Inc. | -6.66 Million USD | -14852.596% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -2539.775% |
| Lumos Pharma, Inc. | -36.57 Million USD | -2624.952% |
| Achilles Therapeutics plc | -70.44 Million USD | -1314.66% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -951.487% |
| 180 Life Sciences Corp. | -22.13 Million USD | -4402.186% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 17195.09% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -40717.125% |
| Nutriband Inc. | -5.12 Million USD | -19356.431% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -808.003% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -1697.725% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -1871.345% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -1426.594% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -1741.649% |
| Palisade Bio, Inc. | -12.28 Million USD | -8014.282% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -2096.128% |
| Beam Therapeutics Inc. | -156.47 Million USD | -536.861% |
| Neurogene Inc. | -52.28 Million USD | -1805.893% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -630.101% |
| AEON Biopharma, Inc. | -48.36 Million USD | -1960.576% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -971.314% |
| Sesen Bio, Inc. | -50.84 Million USD | -1860.1% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -1116.271% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -7968.932% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -133.14% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -847.285% |
| Athira Pharma, Inc. | -116.7 Million USD | -753.89% |
| Vaccinex, Inc. | -19.74 Million USD | -4946.157% |
| HCW Biologics Inc. | -23.57 Million USD | -4126.81% |
| XOMA Corporation | -39.36 Million USD | -2431.668% |
| Nektar Therapeutics | -243.1 Million USD | -309.908% |
| Arvinas, Inc. | -394.8 Million USD | -152.41% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 528178.069% |
| Merus N.V. | -149.2 Million USD | -567.874% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -965.905% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -3087.828% |
| Rezolute, Inc. | -68.42 Million USD | -1356.404% |
| Clene Inc. | -43.24 Million USD | -2204.56% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -6361.566% |
| BeyondSpring Inc. | -21.54 Million USD | -4526.346% |
| Synlogic, Inc. | -55.16 Million USD | -1706.557% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -8147.248% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -9263.982% |
| Peak Bio, Inc. | -1356.23 USD | -73476743.898% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -2969.506% |
| Krystal Biotech, Inc. | 17.9 Million USD | 5665.879% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -741.488% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -191.937% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -21533.121% |
| MannKind Corporation | 15.12 Million USD | 6686.787% |
| Ikena Oncology, Inc. | -74.39 Million USD | -1239.456% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -7813.245% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 5002.42% |
| Gossamer Bio, Inc. | -172.15 Million USD | -478.858% |
| CohBar, Inc. | -12.06 Million USD | -8159.033% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -3806.523% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -3218.951% |
| Legend Biotech Corporation | -477.87 Million USD | -108.531% |
| Mural Oncology plc | -192.72 Million USD | -417.079% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -773.722% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -6072.179% |
| Disc Medicine, Inc. | -91.02 Million USD | -994.771% |
| Champions Oncology, Inc. | -5.05 Million USD | -19617.353% |
| REGENXBIO Inc. | -239.46 Million USD | -316.144% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -9197.421% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -1687.278% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -2470.44% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -783.388% |
| Vaxart, Inc. | -74.72 Million USD | -1233.612% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -2730.342% |
| Cellectis S.A. | -98.09 Million USD | -915.867% |
| Longeveron Inc. | -20.06 Million USD | -4867.672% |
| Repare Therapeutics Inc. | -114.27 Million USD | -772.048% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | -126.895% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -1232.026% |
| Revolution Medicines, Inc. | -430.58 Million USD | -131.434% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -15745.365% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -3136.594% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -1235.99% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 20424.597% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -8988.144% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 121.639% |
| Denali Therapeutics Inc. | -179.97 Million USD | -453.702% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -1046571.498% |
| Veru Inc. | -89.97 Million USD | -1007.539% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -3607.549% |
| Cingulate Inc. | -22.95 Million USD | -4241.729% |
| Passage Bio, Inc. | -98.34 Million USD | -913.326% |
| Context Therapeutics Inc. | -25.06 Million USD | -3876.426% |
| Exicure, Inc. | -15.53 Million USD | -6312.993% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -383.595% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -2595.032% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -16612.771% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -491.53% |
| Nuvalent, Inc. | -149.49 Million USD | -566.601% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -12153.617% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -1060.168% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -3202.124% |
| OmniAb, Inc. | -49.73 Million USD | -1903.811% |
| Anew Medical, Inc. | -1.3 Million USD | -76505.501% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -7959.811% |
| Lipocine Inc. | -16.32 Million USD | -6005.099% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -1394.698% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -1241.15% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -2513.246% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -2454.25% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -4392.246% |
| Sage Therapeutics, Inc. | -545.07 Million USD | -82.823% |
| Ocugen, Inc. | -64.82 Million USD | -1437.191% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -976.499% |
| Q32 Bio Inc. | -86.5 Million USD | -1052.014% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -5787.133% |
| Alumis Inc. Common Stock | -156.89 Million USD | -535.168% |
| Equillium, Inc. | -12.13 Million USD | -8109.878% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -1604.26% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -12508.769% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -5183.476% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -2034.231% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -837.059% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -5471.297% |
| Dominari Holdings Inc. | -22.44 Million USD | -4340.798% |
| Edesa Biotech, Inc. | -8.19 Million USD | -12067.249% |
| vTv Therapeutics Inc. | -25.41 Million USD | -3821.435% |
| Bio-Techne Corporation | 326.66 Million USD | 405.059% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -158.927% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 560.52% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -660.072% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -2562.272% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -559.503% |
| Nkarta, Inc. | -120.48 Million USD | -727.114% |
| BioCardia, Inc. | -11.56 Million USD | -8520.372% |
| Iterum Therapeutics plc | -34.58 Million USD | -2781.767% |